Is ALT5 Sigma Corp (ALTS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 7.5% / 30% | 4.1% / 30% | 15.1% / 30% | 6.74% / 5% | ✗ NOT HALAL |
| DJIM | 7.5% / 33% | 4.1% / 33% | 15.1% / 33% | 6.74% / 5% | ✗ NOT HALAL |
| MSCI | 15.9% / 33% | 8.7% / 33% | 31.9% / 33% | 6.74% / 5% | ✗ NOT HALAL |
| S&P | 7.5% / 33% | 4.1% / 33% | 15.1% / 33% | 6.74% / 5% | ✗ NOT HALAL |
| FTSE | 15.9% / 33% | 8.7% / 33% | 31.9% / 50% | 6.74% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 43.5% | |
| Operating Margin | -218.3% | |
| Net Margin | 133.1% | |
| Return on Equity (ROE) | 4.3% | |
| Return on Assets (ROA) | -1.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $2M |
| Free Cash Flow | $2M |
| Total Debt | $13M |
| Debt-to-Equity | 1.1 |
| Current Ratio | 0.8 |
| Total Assets | $82M |
Price & Trading
| Last Close | $1.32 |
| 50-Day MA | $1.65 |
| 200-Day MA | $3.61 |
| Avg Volume | 3.7M |
| Beta | 2.0 |
|
52-Week Range
$1.08
| |
About ALT5 Sigma Corp (ALTS)
ALT5 Sigma Corporation, together with its subsidiaries, provides blockchain-powered technologies worldwide. It operates through Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. Its products include ALT 5 Prime, an electronic over-the-counter trading platform for the buying and selling of digital assets; and ALT 5 Pay, a crypto-currency payment gateway that enables merchants to accept and make crypto currency payments or integrate the payment platform into their application. The company is also involved identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies for the treatment of pain and addiction. In addition, it develops JAN 101, an oral and sustained-release pharmaceutical composition of sodium nitrite that has completed Phase 2a clinical trial to treat peripheral arterial disease and pain; and JAN123, a formulation of low-dose naltrexone for the treatment of chronic regional pain syndrome. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.
Related Halal Stocks in Technology
Frequently Asked Questions
Is ALT5 Sigma Corp (ALTS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ALT5 Sigma Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ALT5 Sigma Corp's debt ratio?
ALT5 Sigma Corp's debt ratio is 7.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 15.9%.
What are ALT5 Sigma Corp's key financial metrics?
ALT5 Sigma Corp has a market capitalization of $155M, and revenue of $13M. The company maintains a gross margin of 43.5% and a net margin of 133.1%. Return on equity stands at 4.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.